EUVIMEDEUVIMED entdecken
Open Access

Contribution of the APOE Genotype to Cognitive Impairment in Individuals With NOTCH3 Cysteine‐Altering Variants

Yu-Wen Cheng iD, Yi-Chu Liao iD, Chih-Hao Chen iD, Chih-Ping Chung iD, Cathy S J Fann iD, Chien-Ching Chang iD, Yi-Chung Lee iD, Sung-Chun Tang iD

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.123.032689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Yu-Wen Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology National Taiwan University Hospital Taipei Taiwan. Hauptthemen laut MEDLINE: Receptor, Notch3, CADASIL, Cognitive Dysfunction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most prevalent monogenic cerebral small‐vessel disease. Phenotype variability in CADASIL suggests the possible role of genetic modifiers. We aimed to investigate the contributions of the APOE genotype and Neurogenic locus notch homolog protein 3 ( NOTCH3 ) variant position to cognitive impairment associated with CADASIL. Methods and Results Patients with the cysteine‐altering NOTCH3 variant were enrolled in a cross‐sectional study, including the Mini‐Mental State Examination (MMSE), brain magnetic resonance imaging, and APOE genotyping. Cognitive impairment was defined as an MMSE score

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Notch3CADASILCognitive DysfunctionHumansMaleFemaleMiddle AgedCross-Sectional StudiesAgedCysteineGenotypeMagnetic Resonance ImagingGenetic Predisposition to DiseasePhenotypeApolipoproteins ECognitionApolipoprotein E2Mental Status and Dementia TestsRisk Factors

Stichwörter der Autor:innen

APOECADASILNOTCH3cerebral small‐vessel diseasevascular cognitive impairment

Substanzen

Receptor, Notch3NOTCH3 protein, humanCysteineApoE protein, humanApolipoproteins EApolipoprotein E2

Autor:innen und Institutionen

  • Department of Neurology National Taiwan University Hospital Taipei Taiwan.
  • Department of Neurology Taipei Veterans General Hospital Taipei Taiwan.
  • Faculty of Medicine, School of Medicine National Yang Ming Chiao Tung University Taipei Taiwan.
  • Institute of Biomedical Sciences, Academia Sinica Taipei Taiwan.

ORCID-Profile: Yu-Wen Cheng, Yi-Chu Liao, Chih-Hao Chen, Chih-Ping Chung, Cathy S J Fann, Chien-Ching Chang, Yi-Chung Lee, Sung-Chun Tang

Zitieren

APA

Cheng, Y. W., Liao, Y. C., Chen, C. H., Chung, C. P., Fann, C. S. J., Chang, C. C., Lee, Y. C., & Tang, S. C. (2023). Contribution of the APOE Genotype to Cognitive Impairment in Individuals With NOTCH3 Cysteine‐Altering Variants. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032689

Vancouver

Cheng YW, Liao YC, Chen CH, Chung CP, Fann CSJ, Chang CC, et al. Contribution of the APOE Genotype to Cognitive Impairment in Individuals With NOTCH3 Cysteine‐Altering Variants. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.032689

BibTeX
@article{Cheng2023,
  author = {Cheng, Yu-Wen and Liao, Yi-Chu and Chen, Chih-Hao and Chung, Chih-Ping and Fann, Cathy S J and Chang, Chien-Ching and Lee, Yi-Chung and Tang, Sung-Chun},
  title = {Contribution of the APOE Genotype to Cognitive Impairment in Individuals With NOTCH3 Cysteine‐Altering Variants},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.123.032689}
}
Kostenlos starten →